Family · Pharmaceutical analytical standards
Gepirone
An antidepressant of the azapirone family, related to buspirone, that acts as a selective partial agonist of the serotonin 5-HT1A receptor; it was approved in the United States in September 2023 for major depressive disorder in adults. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It took almost forty years to reach patients: synthesised in 1986, it received several negative reviews before its approval in 2023.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
